Prostate cancer screening: massive study gets minimal coverage. Why?

The largest-ever randomized trial of using the prostate-specific antigen (PSA) test in asymptomatic men over the age of 50 has found — after about 10 years of follow-up — no significant difference in prostate cancer deaths among men who were screened with a single (“one-off”) PSA test, and those who weren’t screened.

The findings come from a British study called CAP (“Cluster Randomized Trial of PSA Testing for Prostate Cancer”) published earlier this week in JAMA.

Two things...

What feeling does this article give you?
Joy
Disgust
Fear
Anger
Sadness

#hashtags to follow:

PSA [+]    Prostate Cancer [+]    JAMA [+]   

More #news: